메뉴 건너뛰기




Volumn 93, Issue 444, 2004, Pages 20-22

Pentoxyfylline in and prevention and treatment of chronic lung disease

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Pentoxifylline; Premature infant

Indexed keywords

DEXAMETHASONE; PENTOXIFYLLINE;

EID: 1242315506     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2004.tb03043.x     Document Type: Conference Paper
Times cited : (16)

References (16)
  • 1
    • 0027447078 scopus 로고
    • Xanthine derivatives: Comparison between suppression of tumor necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity
    • Semmler J, Gebert U, Eisenhut T, Moeller J, Schonharting MM, Allera A, et al. Xanthine derivatives: comparison between suppression of tumor necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 1993; 78: 520-5
    • (1993) Immunology , vol.78 , pp. 520-525
    • Semmler, J.1    Gebert, U.2    Eisenhut, T.3    Moeller, J.4    Schonharting, M.M.5    Allera, A.6
  • 4
    • 0025998492 scopus 로고
    • Phase I-II of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation
    • Bianco JA, Appelbaum FR, Nemunaitis J. Phase I-II of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 1993; 78: 1205-11
    • (1993) Blood , vol.78 , pp. 1205-1211
    • Bianco, J.A.1    Appelbaum, F.R.2    Nemunaitis, J.3
  • 5
    • 0031962714 scopus 로고    scopus 로고
    • Effect of pentoxifylline in severe sepsis: Results of a randomized, double-blind, placebo-controlled study
    • Staubach KH, Schroder J, Stuber F, Gehrke K, Traumann E, Zabel P. Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study. Arch Surgery 1998; 133: 94-100
    • (1998) Arch Surgery , vol.133 , pp. 94-100
    • Staubach, K.H.1    Schroder, J.2    Stuber, F.3    Gehrke, K.4    Traumann, E.5    Zabel, P.6
  • 6
    • 0030997420 scopus 로고    scopus 로고
    • Effects of pentoxifylline on hemodynamics and oxygenation in septic and non-septic patients
    • Bacher A, Mayer N, Klimschka W, Oismuller C, Steltzer H, Hammerle A. Effects of pentoxifylline on hemodynamics and oxygenation in septic and non-septic patients. Crit Care Med 1997; 25: 795-800
    • (1997) Crit Care Med , vol.25 , pp. 795-800
    • Bacher, A.1    Mayer, N.2    Klimschka, W.3    Oismuller, C.4    Steltzer, H.5    Hammerle, A.6
  • 7
    • 0032041781 scopus 로고    scopus 로고
    • Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery
    • Hoffmann H, Markewitz A, Kreuzer E, Reichert A, Jochum M, Faist E. Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery. Shock 1998; 19: 234-40
    • (1998) Shock , vol.19 , pp. 234-240
    • Hoffmann, H.1    Markewitz, A.2    Kreuzer, E.3    Reichert, A.4    Jochum, M.5    Faist, E.6
  • 8
    • 0034776922 scopus 로고    scopus 로고
    • Pentoxifylline in perforated peritonitis: Results of a randomised, placebo controlled trial
    • Shukla VK, Ojha AK, Pandey M, Pandey BL. Pentoxifylline in perforated peritonitis: results of a randomised, placebo controlled trial. Eur J Surg 2001; 8: 622-4
    • (2001) Eur J Surg , vol.8 , pp. 622-624
    • Shukla, V.K.1    Ojha, A.K.2    Pandey, M.3    Pandey, B.L.4
  • 9
    • 9244247665 scopus 로고    scopus 로고
    • Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis
    • Lauterbach R, Zembala M. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr 1996; 155: 404-9
    • (1996) Eur J Pediatr , vol.155 , pp. 404-409
    • Lauterbach, R.1    Zembala, M.2
  • 10
    • 0032916980 scopus 로고    scopus 로고
    • Effect of the immunomodulating agent, pentoxifylline in the treatment of sepsis in premature delivered infants: A placebo-controlled, double blind trial
    • Lauterbach R, Pawlik D, Kowalczyk D, Ksyciński W, Helwich E, Zembala M. Effect of the immunomodulating agent, pentoxifylline in the treatment of sepsis in premature delivered infants: a placebo-controlled, double blind trial. Crit Care Med 1999; 27: 807-14
    • (1999) Crit Care Med , vol.27 , pp. 807-814
    • Lauterbach, R.1    Pawlik, D.2    Kowalczyk, D.3    Ksyciński, W.4    Helwich, E.5    Zembala, M.6
  • 11
    • 0031424444 scopus 로고    scopus 로고
    • Serum concentrations of pentoxifylline and its metabolites in premature infants with sepsis when administered by continuous intravenous infusion
    • Szymura-Oleksiak J, Bury J, Lauterbach R, Pawłowski M. Serum concentrations of pentoxifylline and its metabolites in premature infants with sepsis when administered by continuous intravenous infusion. Pharmaceutical Sciences 1997; 3: 367-71
    • (1997) Pharmaceutical Sciences , vol.3 , pp. 367-371
    • Szymura-Oleksiak, J.1    Bury, J.2    Lauterbach, R.3    Pawłowski, M.4
  • 12
    • 9044224023 scopus 로고    scopus 로고
    • Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: Results from a double-blind, randomized, placebo-controlled study
    • Zeni F, Pain P, Vindimian M, Gay JP, Gery P, Bertrand M, Page Y, et al. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med 1996; 24: 207-14
    • (1996) Crit Care Med , vol.24 , pp. 207-214
    • Zeni, F.1    Pain, P.2    Vindimian, M.3    Gay, J.P.4    Gery, P.5    Bertrand, M.6    Page, Y.7
  • 13
    • 0028808117 scopus 로고
    • Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants
    • Little S, Dean T, Bevin S, Hall M, Asthon M, Church M, et al. Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants. Thorax 1995; 50: 1073-9
    • (1995) Thorax , vol.50 , pp. 1073-1079
    • Little, S.1    Dean, T.2    Bevin, S.3    Hall, M.4    Asthon, M.5    Church, M.6
  • 14
    • 0032945865 scopus 로고    scopus 로고
    • The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications
    • Poulakis N, Androutsos G, Kazi D, Bastas A, Provata A, Bitsakou C et al. The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications. Respir Med 1999; 93: 52
    • (1999) Respir Med , vol.93 , pp. 52
    • Poulakis, N.1    Androutsos, G.2    Kazi, D.3    Bastas, A.4    Provata, A.5    Bitsakou, C.6
  • 15
    • 0031060544 scopus 로고    scopus 로고
    • Anti-inflammatory and antifibrotic properties of colchicine: Implications for idiopathic pulmonary fibrosis
    • Entzian P, Schlaak M, Seitzer U, Bufe A, Acil Y, Zabel P. Anti-inflammatory and antifibrotic properties of colchicine: implications for idiopathic pulmonary fibrosis. Lung 1997; 175: 41-51
    • (1997) Lung , vol.175 , pp. 41-51
    • Entzian, P.1    Schlaak, M.2    Seitzer, U.3    Bufe, A.4    Acil, Y.5    Zabel, P.6
  • 16
    • 0033062634 scopus 로고    scopus 로고
    • Nebulized pentoxifylline in successful treatment of five premature neonates with bronchopulmonary dysplasia
    • Lauterbach R, Szymura-Oleksiak J. Nebulized pentoxifylline in successful treatment of five premature neonates with bronchopulmonary dysplasia. Eur J Pediatr 1999; 158: 607
    • (1999) Eur J Pediatr , vol.158 , pp. 607
    • Lauterbach, R.1    Szymura-Oleksiak, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.